Sökning: WFRF:(Ljunghill Hedberg Anna) >
Qdenga® - A promisi...
Qdenga® - A promising dengue fever vaccine; can it be recommended to non-immune travelers?
-
- Angelin, Martin (författare)
- Umeå University,Umeå universitet,Infektionssjukdomar,Department of Clinical Microbiology, Infectious Diseases, Umeå University, Sweden,Umeå Univ, Dept Clin Microbiol, Infect Dis, Umeå, Sweden.
-
- Sjölin, Jan (författare)
- Uppsala University,Uppsala universitet,Infektionsmedicin
-
- Kahn, Fredrik (författare)
- Lund University,Lunds universitet,Infektionsmedicin,Sektion III,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Neutrofiler – nya mekanismer och nya markörer,Forskargrupper vid Lunds universitet,Infection Medicine (BMC),Section III,Department of Clinical Sciences, Lund,Faculty of Medicine,Neutrophils – new mechanisms and new biomarkers,Lund University Research Groups
-
visa fler...
-
- Ljunghill Hedberg, Anna (författare)
- Uppsala University,Uppsala universitet,Infektionsmedicin
-
- Rosdahl, Anja, 1972- (författare)
- Örebro University,Örebro universitet,Institutionen för medicinska vetenskaper,Region Örebro län,School of Medical Sciences, Örebro University, Örebro, Sweden; Department of Infectious Diseases, Örebro University Hospital, Örebro, Sweden,Örebro Univ, Sch Med Sci, Örebro, Sweden.;Örebro Univ Hosp, Dept Infect Dis, Örebro, Sweden.
-
- Skorup, Paul (författare)
- Uppsala University,Uppsala universitet,Infektionsmedicin
-
- Werner, Simon (författare)
- Department of Infectious Diseases, Skåne University Hospital, Region Skåne, Malmö, Sweden,Reg Skane, Skane Univ Hosp, Dept Infect Dis, Malmö, Sweden.
-
- Woxenius, Susanne (författare)
- Department of Infectious Diseases, Sahlgrenska University Hospital, Gothenburg, Sweden,Sahlgrens Univ Hosp, Dept Infect Dis, Gothenburg, Sweden.
-
- Askling, Helena H. (författare)
- Karolinska Institutet,Karolinska Institute
-
visa färre...
-
(creator_code:org_t)
- Elsevier, 2023
- 2023
- Engelska.
-
Ingår i: Travel Medicine and Infectious Disease. - : Elsevier. - 1477-8939 .- 1873-0442. ; 54
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://umu.diva-por... (primary) (Raw object)
-
https://uu.diva-port... (primary) (Raw object)
-
http://dx.doi.org/10... (free)
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
https://urn.kb.se/re...
-
https://urn.kb.se/re...
-
https://lup.lub.lu.s...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- Qdenga® has been approved by the European Medicines Agency (EMA) for individuals > 4 years of age and for use according to national recommendations. The vaccine shows high efficacy against virologically confirmed dengue and severe dengue in clinical studies on 4–16-year old's living in endemic areas. For individuals 16–60 years old only serological data exists and there is no data for individuals > 60 years. Its use as a travel vaccine is still unclear. We present the studies behind the approval and the recommendations for travelers as issued by the Swedish Society for Infectious Diseases Physicians.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Infektionsmedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Infectious Medicine (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Hälsovetenskap -- Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Health Sciences -- Public Health, Global Health, Social Medicine and Epidemiology (hsv//eng)
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas